Lightning Session 2

Co-Moderator(s)

• JJ

  Jessica Jalbert, PhD (she/her/hers)

  Executive Director - HEOR-Epidemiology
  Regeneron
• 

  Robert Platt, PhD (he/him/his)

  Professor
  Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
  Montreal, Canada
• MR

  Mary Beth Ritchey, PhD, FISPE

  Food and Drug Administration
  Philadelphia, United States
• 

  Leo Russo, PhD

  VP, Global Medical Epidemiology
  Pfizer
  Collegeville, United States

Presentations:

• 1:00 PM – 1:05 PM ADT

  Genetic variants and social benefit use in premenopausal breast cancer patients treated with docetaxel: a Danish population-based cohort study
  

  Presenting Author: Julie A. Schmidt, MSc, DPhil (she/her/hers) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
• 1:05 PM – 1:10 PM ADT

  Structural Racism and Inequities in Real-World Treatment and Survival Among Patients with Four Solid-Tumor Cancers
  

  Presenting Author: Harlan R. Pittell, PhD (he/him/his) – Flatiron Health
• 1:10 PM – 1:15 PM ADT

  Patient Diversity and Personalized Treatment of Non-Small Cell Lung Cancer
  

  Presenting Author: Carla Y. Vossen, PhD – Syneos Health
• 1:15 PM – 1:20 PM ADT

  Pharmacist Prescribing in Nova Scotia: Uptake and Adaptation to Policy-Related Changes
  

  Presenting Author: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University
• 1:30 PM – 1:35 PM ADT

  Emulated Target Trial Assessing The Effect Of Empiric Potassium Supplementation On All-Cause Mortality Among Furosemide Initiators
  

  Presenting Author: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
• 1:35 PM – 1:40 PM ADT

  Effects of SGLT2 inhibitors on anemia in patients with diabetes and chronic kidney disease: A population-based cohort study using target trial emulation framework
  

  Presenting Author: Jia-Chian Hu, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
• 1:40 PM – 1:45 PM ADT

  Risk of stroke with various types of menopausal hormone therapy: A Swedish nationwide Register-based Emulated Target trial
  

  Presenting Author: Therese Johansson – Department of Immunology, Genetics and Pathology, Uppsala University
• 1:45 PM – 1:50 PM ADT

  A causal inference approach to evaluate the effect of Comprehensive Medication Reviews on all-cause mortality among Medicare beneficiaries
  

  Presenting Author: Daniela C. Moga, MD, PhD (she/her/hers) – Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, USA
• 2:00 PM – 2:05 PM ADT

  The EU Vaccine Monitoring Platform: a New Framework Leveraging European Union Pharmacoepidemiological Expertise and Data Sources to Monitor the Effectiveness and Safety of Vaccines
  

  Presenting Author: Catherine Cohet, PhD (she/her/hers) – European Medicines Agency
• 2:05 PM – 2:10 PM ADT

  VAC4EU Study Tracking Post-Authorization Safety of mRNA-1273 in Five European Countries: How to Overcome the Methodological Challenges
  

  Presenting Author: Brianna M. Goodale, PhD – Julius Clinical Research
• 2:10 PM – 2:15 PM ADT

  The Contribution of Immunization Information System Data to Claims-Based Vaccine Administration Capture Over Time and Implications for Claims-Based COVID-19 Vaccine Studies
  

  Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
• 2:15 PM – 2:20 PM ADT

  Interpretating Relative Vaccine Effectiveness: Challenges and Real Examples from the REFORCO-Brazil Study on COVID-19 Vaccines
  

  Presenting Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK